drugset / Trial / NCT00871247

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

NCT00871247

Phase 1 Completed 26 enrolled Actavis Inc.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck \& Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1 x 5 mg tablet, under fed conditions.

Timeline

Start
2004-11
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 5 mg

Indications

No indication recorded.